Drugs / CB4211
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03998514 | Jul 2018 → Apr 2021 | NAFLD1 | CohBar, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CB4211 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03998514 ↗ |
| Route | Subcutaneous | “Administered by subcutaneous injection” NCT03998514 ↗ |